J Cancer 2022; 13(2):450-464. doi:10.7150/jca.68264 This issue Cite

Review

The new insight of treatment in Cholangiocarcinoma

Yuhang Li1*, Yinghui Song1,2*, Sulai Liu1,2,3✉

1. Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, 410005 Hunan Province, China.
2. Hunan Research Center of Biliary Disease, Changsha, 410005 Hunan Province, China.
3. Central Laboratory of Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, 410015, China.
*These authors contributed equally to this work.

Citation:
Li Y, Song Y, Liu S. The new insight of treatment in Cholangiocarcinoma. J Cancer 2022; 13(2):450-464. doi:10.7150/jca.68264. https://www.jcancer.org/v13p0450.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cholangiocarcinoma (CCA) is a relatively rare malignant tumor originating from the bile duct epithelial cells, and it is one of the malignant tumors with fast growth in incidence and death rate in recent years. CCA carries a very poor prognosis due to a typically late clinical presentation and a poor response to current therapeutics. Currently, surgery is the only possible curative treatment, radiotherapy and chemotherapy also play an important role in slowing down disease progression, while targeted therapy and immunotherapy are changing with each passing day and their combined effect may have great potential for the treatment of CCA; Clinical trials of various treatment options for CCA are also being conducted. This article reviews the different treatment options for CCA and explores the adjuvant treatment for it from a new perspective. In the future, the goal of treatment should be multiple and combined for different CCA patients to achieve individualized programs and improve overall survival.

Keywords: Cholangiocarcinoma, Insight, Treatment


Citation styles

APA
Li, Y., Song, Y., Liu, S. (2022). The new insight of treatment in Cholangiocarcinoma. Journal of Cancer, 13(2), 450-464. https://doi.org/10.7150/jca.68264.

ACS
Li, Y.; Song, Y.; Liu, S. The new insight of treatment in Cholangiocarcinoma. J. Cancer 2022, 13 (2), 450-464. DOI: 10.7150/jca.68264.

NLM
Li Y, Song Y, Liu S. The new insight of treatment in Cholangiocarcinoma. J Cancer 2022; 13(2):450-464. doi:10.7150/jca.68264. https://www.jcancer.org/v13p0450.htm

CSE
Li Y, Song Y, Liu S. 2022. The new insight of treatment in Cholangiocarcinoma. J Cancer. 13(2):450-464.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.